Vaping or nicotine replacement: what helps adults stop smoking?

Where can you get help with the next attempt?

NHS stop-smoking services offer free expert support. A GP or pharmacist can help you find the local route. Services may offer individual, group, phone or online sessions; ask about a format you can attend around work or caring responsibilities.

A useful appointment can begin with one difficult moment from a previous attempt: 'The urge was strongest before my shift, and I did not know what I could use then.' Ask what to do when cravings break through, how to check your technique and who to contact if you smoke before the next appointment.

Consider the practical setting too. If cigarettes are routinely offered during a break, tell the people involved what you are trying to change and what support would help. You might ask them not to offer one, or arrange a different break together. Our habit-planning guide can help organise a specific cue and action alongside treatment for nicotine dependence.

Keep the answers accessible, including the next review date. Before leaving the appointment, be able to explain your plan in your own words: the goal for cigarettes, the product and instructions you will use, what you will do when the difficult craving arrives, and how you will get help if the arrangement needs changing.

Would a patch plus a faster-acting product fit your cravings?

Nicotine replacement therapy, or NRT, supplies nicotine without the harmful mixture from burning tobacco. Patches provide a steady background supply, while gum, lozenges, sprays or an inhaler can address cravings as they arise. The NHS recommends combining slow- and fast-acting products for the best results.

Product technique matters. Nicotine gum is chewed and then parked against the inside of the cheek, rather than continuously chewed like ordinary gum. A lozenge is sucked and rested beside the cheek. An inhaler delivers nicotine through the mouth and throat while providing a hand-to-mouth action. Follow the particular product's instructions and ask a pharmacist or adviser to demonstrate if necessary.

A twenty-four-hour patch can help with cravings on waking; a sixteen-hour patch is worn during waking hours. Ask which type and strength fit your smoking pattern and how to use a faster-acting product alongside it. The NHS describes treatment commonly lasting around twelve weeks, or longer when needed to avoid returning to smoking.

'NRT did not work' can therefore hide several different experiences. Perhaps the patch irritated your skin, the urge before work remained strong, or you stopped treatment early because you were uncertain about duration. Describe that event rather than treating every possible NRT combination as one failed treatment.

What should you check before choosing a vape?

A vape heats liquid into an aerosol instead of burning tobacco. NHS guidance advises using enough nicotine to control cravings when switching, with help choosing strength from a stop-smoking adviser or reputable retailer. Some services provide starter packs. The hand-to-mouth action can also matter to people accustomed to smoking.

In the UK, businesses have been prohibited from selling or supplying single-use vapes since 1 June 2025. Reusable devices must be rechargeable and refillable, including through replacement prefilled pods. If they contain a coil, it must be replaceable, either separately or within a replacement pod. Refills should be available separately.

That gives you practical questions to ask: can you refill or replace the pod yourself, are compatible supplies readily available, and can someone show you how to maintain the device? A starter pack is less useful if you cannot obtain the next refill or understand when a component needs replacing.

MHRA rules for consumer products set a maximum nicotine concentration of 20 mg/mL. A higher-strength product described in an overseas trial is not a UK buying instruction. Regulation also should not be read as proof of harmlessness or as a personalised recommendation for the maximum strength.

The NHS also allows using a nicotine patch alongside a vape: the patch provides background nicotine while vaping addresses immediate cravings. Discuss the combination and any ongoing difficulty rather than assuming you must choose one product in isolation.

Write down what you will use when the strongest urge tends to occur. If you repeatedly return to cigarettes at that moment, contact the adviser to review the product, technique or plan. Simply buying another device without identifying the difficulty can leave the original problem untouched.

How much did quitting rates differ in trials?

A 2019 UK trial enrolled 886 adults through stop-smoking services. They received a refillable e-cigarette starter pack or their choice of nicotine replacement products, including combinations. Both groups had weekly behavioural support for at least four weeks.

At one year, sustained smoking abstinence checked with a biological measure was 18.0% with e-cigarettes and 9.9% with nicotine replacement. That is about eight additional people abstinent per hundred assigned to vaping in this programme. Participants missing from follow-up or without verification were counted as smoking.

Among those who successfully stopped smoking, 80% of the e-cigarette group still used their assigned product at one year, compared with 9% of the nicotine-replacement group. The improved cigarette outcome came with much more continued product use. Mouth or throat irritation was more common with e-cigarettes; nausea was more common with nicotine replacement. The trial was funded by the NIHR and Cancer Research UK.

A January 2026 US trial recruited 350 quitline users still smoking after an earlier attempt. It compared one e-cigarette product with patches plus lozenges, providing eight weeks of products and three counselling calls. At eight weeks, verified abstinence over the preceding seven days was 14.3% versus 9.7%.

That difference was not statistically significant. The odds-ratio estimate was 1.56, with a 95% confidence interval from 0.80 to 3.04, spanning no difference. Recruitment and quit rates were lower than expected. The trial established neither superiority nor equivalence: the uncertainty was too wide for either conclusion.

The US trial's last-week abstinence and the UK trial's sustained one-year abstinence are different outcomes in different populations. Its calls covered a quit date, product use, urges, removing smoking equipment and social support. Comparing the percentages alone would lose both the outcome definition and the treatment setting.

The wider review is useful because a single inconclusive trial cannot describe the whole evidence base. Equally, an average advantage across trials cannot tell you whether a particular device, strength or routine will suit you. That is where product technique and support become important.

What if you stop smoking but still use nicotine?

The NHS describes vaping as less harmful than smoking, but not risk-free. Long-term risks remain under study. The full benefit of switching requires stopping cigarettes completely; continuing to smoke alongside vaping is different from the abstinence measured in the trials.

A 2026 secondary analysis revisited the same 886 people in the UK trial. Among participants who had stopped at four weeks, relapse by one year was lower in the originally assigned vaping group, with a relative risk of 0.78 and a 95% confidence interval of 0.64 to 0.96. Continued vaping was also associated with less relapse.

This was a further analysis of an existing trial, not another independent group of 886 people. Successful quitters were not newly randomised to continue or stop vaping. The association therefore cannot establish the ideal duration for every person, and the study does not demonstrate lifelong safety.

If an aid is helping you remain smoke-free, agree when and how to review it. Becoming nicotine-free can be a later goal, considered alongside the risk of returning to cigarettes. Write the two goals separately so that progress on stopping smoking is not mistaken for completion of both.

Which other options should you discuss?

NHS information on nicotine-free medicines describes varenicline, cytisine and bupropion. Varenicline and cytisine reduce nicotine's rewarding effects and cravings; bupropion acts on brain chemicals involved in cravings and withdrawal. Ask a GP or stop-smoking service about suitability and access, including your current medicines and previous side effects.

During pregnancy, licensed NRT is the NHS-recommended option, with advice from a midwife or stop-smoking adviser. General adult trial results cannot select an individual's pregnancy treatment.

Bring the names of products you have tried rather than relying on memory of a brand colour or package. Note what you used, how long you used it, what helped and why you stopped. If you are considering changing a prescribed medicine or combining treatments, make that an explicit question for the professional supporting the attempt.